Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

ASTRAZENECA PHARMACEUTICALS LP

Subsidiary ofASTRAZENECA PLCUEI: E5K2ZJ8CTJH4CAGE: 36WK2

ASTRAZENECA PHARMACEUTICALS LP is a federal contractor, registered under UEI E5K2ZJ8CTJH4 and CAGE code 36WK2. It has been awarded $1,388,100,500 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing, Unknown NAICS, and Other NAICS codes (4 codes, <0.5% each). Top awarding agencies include Department Of Defense, Department Of Health And Human Services, and Other agencies (2 agencies, <0.5% each).

Contact Information

Registration and classification details

Registration

UEI Code

E5K2ZJ8CTJH4

CAGE Code

36WK2

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationForeign OwnedManufacturer of Goods

NAICS Codes

325412Pharmaceutical Preparation Manufacturing(Primary)
541713Research and Development in Nanotechnology

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Astrazeneca Pharmaceuticals LP specializes in the manufacturing of sterile pharmaceutical preparations, with deep expertise in vaccine production and branded therapeutics for public health programs. The company delivers critical influenza vaccines for pediatric and adult populations, alongside speci...

Astrazeneca Pharmaceuticals LP specializes in the manufacturing of sterile pharmaceutical preparations, with deep expertise in vaccine production and branded therapeutics for public health programs. The company delivers critical influenza vaccines for pediatric and adult populations, alongside specialty medications such as acalabrutinib tablets, demonstrating proficiency in aseptic processing, cold chain logistics, and FDA-compliant batch documentation. Their technical capabilities include GMP manufacturing, stability testing, and regulatory submission support for both seasonal and pandemic-ready immunization platforms, with a focus on scalable, high-volume production to meet federal surge requirements. The contractor maintains consistent, long-term relationships with the Department of Health and Human Services, primarily supplying influenza vaccines under national preparedness initiatives, and serves the Department of Veterans Affairs with specialty pharmaceuticals for chronic disease management. A single award to the Department of Defense indicates capacity to support military medical readiness through non-vaccine medicinal products, suggesting flexibility across defense and civilian health missions. Their primary industry focus is pharmaceutical preparation manufacturing (NAICS 325412), with secondary activity in medicinal and botanical manufacturing (NAICS 325411), positioning them as a trusted supplier of clinically essential, high-compliance therapeutics for government health systems. They operate with precision in regulatory frameworks governing biologics, antivirals, and oral oncology agents, aligning with CDC, NIH, and VA formulary needs. Astrazeneca Pharmaceuticals LP is a large-scale, privately held manufacturer headquartered in Wilmington, Delaware, with no active federal certifications on record. Their geographic footprint is anchored in U.S.-based GMP facilities optimized for federal supply chain reliability, serving as a key non-governmental partner in national immunization and pharmaceutical security infrastructure.

Key Performance Metrics

Awards Count

217

All time

Active

1

Currently performing

Completed

216

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Export
325412 - Pharmaceutical Preparation Manufacturing$1.4B99.1%
- Unknown NAICS$11.4M0.8%
Others - Other NAICS codes (4 codes, <0.5% each)$462.9K0%
Awards by Agency Over Time
Awards by Place of Performance

Compete with ASTRAZENECA PHARMACEUTICALS LP

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for ASTRAZENECA PHARMACEUTICALS LP

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in ASTRAZENECA PHARMACEUTICALS LP's top NAICS codes and agencies

NAICS: 541330
New
Federal
Department of War Office of the Assistant Secretary of War OASW(EI&E) Resilient Infrastructure and Layered Passive Survivability
Solicitation # JP10212026
The Department of War, through the Office of the Assistant Secretary of War for Energy, Installations, and Environment, has issued Request for Information JP10212026 to gather concepts and technical insights for the development of the Base of the Future. This initiative focuses on transitioning installation frameworks to support an active operational posture by enhancing resilient infrastructure and layered passive survivability. The Department is seeking non-prescriptive solutions to move beyond traditional hardening methods, focusing instead on minimizing target signatures, dynamically absorbing kinetic energy, and maintaining mission-essential functions during active degradation. The scope of this market research is divided into four capability-based domains: advanced materials and physical hardening, subterranean and deep-earth engineering, signature management and deception, and spatial dispersal and system-level resilience. The government intends to use the gathered information to identify mature technologies for immediate integration into military construction standards and to guide future research and development funding. This RFI is issued solely for planning purposes and does not constitute a solicitation or a binding contract. Responses must be unclassified, delivered in a searchable PDF format, and limited to twenty pages, excluding technical drawings and capability statements. Submissions must include a cover sheet with the company name, point of contact, CAGE code, and corporate capability designation. The response deadline is November 6, 2026.
Department Of Defense

POSTED

1 day ago

DEADLINE

in 15 days
View Details
NAICS: 336992
New
Federal
Tactical Wheeled Vehicle (TWV) Industry Engagement Interest & Security Registration Form
Solicitation # W912CH-26-I-TWV1
The Department of Defense, through the Portfolio Acquisition Executive for Agile Sustainment and Ammunition, is conducting a multi-phase Tactical Wheeled Vehicle (TWV) Industry Engagement under presolicitation W912CH-26-I-TWV1. This initiative aims to move away from rigid procurement models toward agile contracting to develop survivable and cost-effective light-duty (under 8,500 lbs GVW) and medium-duty (8,500 to 16,000 lbs GVW) vehicle fleets. The primary goal is to leverage industry innovation and data-driven insights to inform the Army's strategic programming and budgeting for the Fiscal Year 2030 Program Objective Memorandum cycle. Phase 1 of this engagement consists of interactive briefings and vignettes scheduled for November 9 to 10, 2026, in Ann Arbor, Michigan. The event includes government-led sessions on Army challenges, industry input on problem statements, and limited one-on-one sessions for discussing proprietary concepts. Due to the event being designated as Controlled Unclassified Information with Distribution Statement C, participants must be U.S. citizens and provide an active DD Form 2345 through the Joint Certification Program. Interested organizations are limited to three representatives and must submit their registration and security certifications by October 28, 2026.
Department Of Defense

POSTED

1 day ago

DEADLINE

in 6 days
View Details